Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Misidentification of preformed anti-HLA-DP antibodies leads to antibody-mediated kidney transplant rejection: a case report ; volume:23 ; number:1 ; day:17 ; month:5 ; year:2022 ; pages:1-7 ; date:12.2022
BMC nephrology ; 23, Heft 1 (17.5.2022), 1-7, 12.2022
- Creator
-
Thammanichanond, Duangtawan
Tammakorn, Chutima
Ingsathit, Atiporn
Worawichawong, Suchin
Sangkum, Premsant
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12882-022-02807-6
- URN
-
urn:nbn:de:101:1-2022072321194934432643
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Thammanichanond, Duangtawan
- Tammakorn, Chutima
- Ingsathit, Atiporn
- Worawichawong, Suchin
- Sangkum, Premsant
- SpringerLink (Online service)
Other Objects (12)
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Antibody-mediated rejection with detection of de-novo donorspecific anti-hla class ii antibodies 3 years after heart transplantation: a case report
Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Cardiac magnetic resonance T1 mapping pre and post contrast in heart transplant patients with clinical antibody-mediated rejection: a preliminary experience
Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Antibody-mediated rejection with detection of de-novo donorspecific anti-hla class ii antibodies 3 years after heart transplantation: a case report
Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Cardiac magnetic resonance T1 mapping pre and post contrast in heart transplant patients with clinical antibody-mediated rejection: a preliminary experience
Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Antibody-mediated rejection with detection of de-novo donorspecific anti-hla class ii antibodies 3 years after heart transplantation: a case report
Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Cardiac magnetic resonance T1 mapping pre and post contrast in heart transplant patients with clinical antibody-mediated rejection: a preliminary experience
Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study